Clinical (prescription) cannabis products were being rescheduled in britain in 2018 — this permitted expert Medical practitioners to prescribe cannabis-based medicines in a very restricted list of circumstances. Access through the NHS continues to be tightly limited: cannabis-primarily based goods u